PAOS ..$0.16..Complete DD package
Homepage:
http://www.precaeroinc.com
Company description:
"PRECISION AEROSPACE COMPONENTS INC. is a provider of quality aerospace components. The Company's vision is to build a leading aerospace component, fabrication and service business. Management plans to grow the company through a combination of product line expansions and strategic acquisitions."
Filings:
http://www.sec.gov/cgi-bin/browse-edgar?compa...getcompany
Latest press release:
http://www.sec.gov/Archives/edgar/data/936446...x99one.htm
Share count (july 2012):
Oustanding shares: 3,68 million shares
Preferred shares oustanding: 5.94 million shares (convertible into 9.24 million common shares)
Fully diluted share count: 12.92 million shares
Float only 1.2 million shares
Investment thesis:
Company is profitable on a fully diluted basis right now on about 8 million in sales and and it reports with the SEC.
Now they aquired "Fastener distribution and marketing company" for 9.3 million USD paid with a revolving loan and no equity. That's pretty significant for such a small company to make a 10 million aquisition without any equity.
http://www.sec.gov/Archives/edgar/data/936446...k53112.htm
They project 33 million in sales and 3 million in pre tax operating profit for a 12 month period.
"In the upcoming 12 months, the combined companies anticipate producing over $33M in revenues and an operating profit (before any expenses associated with the acquisition and taxes) of over $3M"
http://www.sec.gov/Archives/edgar/data/936446...x99one.htm
The fully diluted market cap right now is only about 2 million for a company which guides for about 33 million in sales on a yearly basis with the new aquisition while they are already profitable on 8 million sales. They guide for 3 million in pre tax operating income as well. How much of that will go down to the bottom line eventually? It could be enormous.
Their actual outstanding shares is only 3.6 million with 62% held by management but they also have preferreds outstanding. The good thing is that 89% of the preferreds are held by management as well. That leaves a float of about 1.2 million at this moment. Stock is very thin and went up quite nicely lately. I wanted to post this at 8 cents 10 days ago and had it prepared but then I waited since it started to move. I do however think 15-20 cents is still very attractive if they come through with their guidance and do not blow up something else.
PAOS..$0.16..Complete DD package Homepage:
Top 10 Most Recent News Articles
Tam-Peli Steps Up in SCLC Battle: Trial Insights
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
Trial Disappointment: No Significant Gains in NSCLC
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue ReadingTop 5 Most Recently Viewed Articles
Rocky Shore Gold Completes Initial Private Placement Tranche
Rocky Shore Gold Completes Initial Private Placement Tranche Rocky Shore Gold Ltd. (CSE: RSG) has successfully announced the completion of the first tranche of its non-brokered private placement, raising significant funds to support its ongoing projects. The financing initiative, which was previously publicized, demonstrates the company's commitment to advancing its...
Continue Reading
Monthly Dividend Announcement from Ellington Credit Company
Ellington Credit Company Declares Monthly Dividend Ellington Credit Company (NYSE: EARN) has made an exciting announcement regarding its financial commitment to its shareholders. The company's Board of Trustees has declared a monthly common dividend, establishing an amount of $0.08 per share. This dividend will be payable shortly, offering a tangible return to those...
Continue Reading
Halide Alagoz Sells Over $1.5 Million in Ralph Lauren Shares
Halide Alagoz Completes Significant Stock Sale Recent reports indicate that Halide Alagoz, the Chief Product Officer at Ralph Lauren, executed a substantial insider sale according to official filings. Details of the Insider Transaction According to regulatory disclosures, Alagoz sold 5,282 shares of Ralph Lauren, resulting in a total transaction value of approximately...
Continue Reading
Midland States Bancorp, Inc. Declares Quarterly Dividends
Midland States Bancorp, Inc. Declares Quarterly Cash Dividend Midland States Bancorp, Inc. (NASDAQ: MSBI) recently announced a quarterly cash dividend of $0.31 per share for its common stock. This dividend is significant as it highlights the company’s commitment to delivering value to its shareholders. The payment will be available to shareholders of record on a...
Continue Reading
Standex International Sees Price Target Increase Amid Growth
Standex International's Price Target Raised by DA Davidson Recently, Standex International (NYSE: SXI) experienced a notable increase in its price target, now set at $222.00, from analysts at DA Davidson. This update follows the company's fiscal year 2025 earnings report, coinciding with their performance in the third quarter of the calendar year. The previous price...
Continue Reading